» Articles » PMID: 34286587

Different Folding States from the Same Protein Sequence Determine Reversible Vs Irreversible Amyloid Fate

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2021 Jul 21
PMID 34286587
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The propensity to self-assemble into amyloid fibrils with a shared cross-β architecture is a generic feature of proteins. Amyloid-related diseases affect millions of people worldwide, yet they are incurable and cannot be effectively prevented, largely due to the irreversible assembly and extraordinary stability of amyloid fibrils. Recent studies suggest that labile amyloids may be possible in certain proteins containing low-complexity domains often involved in the formation of subcellular membraneless organelles. Although the fundamental understanding of this reversible amyloid folding process is completely missing, the current view is that a given protein sequence will result in either irreversible, as in most of the cases, or reversible amyloid fibrils, as in few exceptions. Here we show that two common globular proteins, human lysozyme and its homologue from hen egg white, can self-assemble into both reversible and irreversible amyloid fibrils depending on the folding path followed by the protein. In both folding states, the amyloid nature of the fibrils is demonstrated at the molecular level by its cross-β structure, yet with substantial differences on the mesoscopic polymorphism and the labile nature of the amyloid state. Structural analysis shows that reversible and irreversible amyloid fibrils possess the same full-length protein sequence but different fibril core structures and β-sheet arrangements. These results illuminate a mechanistic link between the reversible and irreversible nature of amyloids and highlight the central role of protein folding states in regulating the lability and reversibility of amyloids.

Citing Articles

On the reversibility of amyloid fibril formation.

Palmadottir T, Getachew J, Ortigosa-Pascual L, Axell E, Wei J, Olsson U Biophys Rev (Melville). 2025; 6(1):011303.

PMID: 39973975 PMC: 11836874. DOI: 10.1063/5.0236947.


A structural rationale for reversible vs irreversible amyloid fibril formation from a single protein.

Frey L, Zhou J, Cereghetti G, Weber M, Rhyner D, Pokharna A Nat Commun. 2024; 15(1):8448.

PMID: 39349464 PMC: 11442456. DOI: 10.1038/s41467-024-52681-z.


Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research.

Shoemaker R, Larsen R, Larsen P Front Immunol. 2024; 15:1426656.

PMID: 39238639 PMC: 11374656. DOI: 10.3389/fimmu.2024.1426656.


Assessing the Catalytic Role of Native Glucagon Amyloid Fibrils.

Nandi A, Zhang A, Arad E, Jelinek R, Warshel A ACS Catal. 2024; 14(7):4656-4664.

PMID: 39070231 PMC: 11270920. DOI: 10.1021/acscatal.4c00452.


Formation of Calprotectin Inhibits Amyloid Aggregation of S100A8 and S100A9 Proteins.

Baronaite I, Sulskis D, Kopu Stas A, Tutkus M, Smirnovas V ACS Chem Neurosci. 2024; 15(9):1915-1925.

PMID: 38634811 PMC: 11066842. DOI: 10.1021/acschemneuro.4c00093.